
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer
Chiara Luise, Maria Capra, Maddalena Donzelli, et al.
PLoS ONE (2011) Vol. 6, Iss. 1, pp. e15891-e15891
Open Access | Times Cited: 92
Chiara Luise, Maria Capra, Maddalena Donzelli, et al.
PLoS ONE (2011) Vol. 6, Iss. 1, pp. e15891-e15891
Open Access | Times Cited: 92
Showing 1-25 of 92 citing articles:
Deubiquitinases in cancer: new functions and therapeutic options
Julia M. Fraile, Vı́ctor Quesada, David Rodrı́guez, et al.
Oncogene (2011) Vol. 31, Iss. 19, pp. 2373-2388
Open Access | Times Cited: 429
Julia M. Fraile, Vı́ctor Quesada, David Rodrı́guez, et al.
Oncogene (2011) Vol. 31, Iss. 19, pp. 2373-2388
Open Access | Times Cited: 429
BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5
Junying Qin, Zhongmei Zhou, Wenlin Chen, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 172
Junying Qin, Zhongmei Zhou, Wenlin Chen, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 172
La FAM fatale: USP9X in development and disease
Mariyam Murtaza, Lachlan A. Jolly, Jozef Gécz, et al.
Cellular and Molecular Life Sciences (2015) Vol. 72, Iss. 11, pp. 2075-2089
Open Access | Times Cited: 170
Mariyam Murtaza, Lachlan A. Jolly, Jozef Gécz, et al.
Cellular and Molecular Life Sciences (2015) Vol. 72, Iss. 11, pp. 2075-2089
Open Access | Times Cited: 170
USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy
Iraia García‐Santisteban, Godefridus J. Peters, Elisa Giovannetti, et al.
Molecular Cancer (2013) Vol. 12, Iss. 1
Open Access | Times Cited: 158
Iraia García‐Santisteban, Godefridus J. Peters, Elisa Giovannetti, et al.
Molecular Cancer (2013) Vol. 12, Iss. 1
Open Access | Times Cited: 158
The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-like Traits to Breast Cancer Cells
Yadi Wu, Yifan Wang, Xiuwei H. Yang, et al.
Cell Reports (2013) Vol. 5, Iss. 1, pp. 224-236
Open Access | Times Cited: 151
Yadi Wu, Yifan Wang, Xiuwei H. Yang, et al.
Cell Reports (2013) Vol. 5, Iss. 1, pp. 224-236
Open Access | Times Cited: 151
Deubiquitinases and the new therapeutic opportunities offered to cancer
Roland Pfoh, Ira Kay Lacdao, V. Saridakis
Endocrine Related Cancer (2015) Vol. 22, Iss. 1, pp. T35-T54
Open Access | Times Cited: 126
Roland Pfoh, Ira Kay Lacdao, V. Saridakis
Endocrine Related Cancer (2015) Vol. 22, Iss. 1, pp. T35-T54
Open Access | Times Cited: 126
USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression
Randy S. Schrecengost, Jeffry L. Dean, Jonathan F. Goodwin, et al.
Cancer Research (2013) Vol. 74, Iss. 1, pp. 272-286
Open Access | Times Cited: 115
Randy S. Schrecengost, Jeffry L. Dean, Jonathan F. Goodwin, et al.
Cancer Research (2013) Vol. 74, Iss. 1, pp. 272-286
Open Access | Times Cited: 115
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types
Zhongqi Ge, Jake Leighton, Yumeng Wang, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 213-226.e3
Open Access | Times Cited: 102
Zhongqi Ge, Jake Leighton, Yumeng Wang, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 213-226.e3
Open Access | Times Cited: 102
De Novo Loss-of-Function Mutations in USP9X Cause a Female-Specific Recognizable Syndrome with Developmental Delay and Congenital Malformations
Margot R.F. Reijnders, Vasilios Zachariadis, Brooke Latour, et al.
The American Journal of Human Genetics (2016) Vol. 98, Iss. 2, pp. 373-381
Open Access | Times Cited: 96
Margot R.F. Reijnders, Vasilios Zachariadis, Brooke Latour, et al.
The American Journal of Human Genetics (2016) Vol. 98, Iss. 2, pp. 373-381
Open Access | Times Cited: 96
Targeting deubiquitinase USP28 for cancer therapy
Xiaofang Wang, Zhiyi Liu, Li Zhang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 88
Xiaofang Wang, Zhiyi Liu, Li Zhang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 88
The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.
Yaqin Tu, Chen Cai, Junru Pan, et al.
PubMed (2012)
Closed Access | Times Cited: 101
Yaqin Tu, Chen Cai, Junru Pan, et al.
PubMed (2012)
Closed Access | Times Cited: 101
K63-Linked Ubiquitination in Kinase Activation and Cancer
Guocan Wang, Yuan Gao, Li Li, et al.
Frontiers in Oncology (2012) Vol. 2
Open Access | Times Cited: 97
Guocan Wang, Yuan Gao, Li Li, et al.
Frontiers in Oncology (2012) Vol. 2
Open Access | Times Cited: 97
A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature
Pascal O. Zinn, Pratheesh Sathyan, Bhanu Mahajan, et al.
PLoS ONE (2012) Vol. 7, Iss. 8, pp. e41522-e41522
Open Access | Times Cited: 88
Pascal O. Zinn, Pratheesh Sathyan, Bhanu Mahajan, et al.
PLoS ONE (2012) Vol. 7, Iss. 8, pp. e41522-e41522
Open Access | Times Cited: 88
Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication
Mingjing He, Zhuan Zhou, George Y. Wu, et al.
Pharmacology & Therapeutics (2017) Vol. 177, pp. 96-107
Open Access | Times Cited: 86
Mingjing He, Zhuan Zhou, George Y. Wu, et al.
Pharmacology & Therapeutics (2017) Vol. 177, pp. 96-107
Open Access | Times Cited: 86
The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics
Mingjing He, Zhuan Zhou, Anil A. Shah, et al.
Cell & Bioscience (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 85
Mingjing He, Zhuan Zhou, Anil A. Shah, et al.
Cell & Bioscience (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 85
Naturally Occurring Isothiocyanates Exert Anticancer Effects by Inhibiting Deubiquitinating Enzymes
Ann P. Lawson, Marcus J. C. Long, Rory Coffey, et al.
Cancer Research (2015) Vol. 75, Iss. 23, pp. 5130-5142
Open Access | Times Cited: 73
Ann P. Lawson, Marcus J. C. Long, Rory Coffey, et al.
Cancer Research (2015) Vol. 75, Iss. 23, pp. 5130-5142
Open Access | Times Cited: 73
USP51 promotes deubiquitination and stabilization of ZEB1.
Zhicheng Zhou, Peijing Zhang, Xiaoyu Hu, et al.
PubMed (2017) Vol. 7, Iss. 10, pp. 2020-2031
Closed Access | Times Cited: 69
Zhicheng Zhou, Peijing Zhang, Xiaoyu Hu, et al.
PubMed (2017) Vol. 7, Iss. 10, pp. 2020-2031
Closed Access | Times Cited: 69
Gli1‐induced deubiquitinase USP 48 aids glioblastoma tumorigenesis by stabilizing Gli1
Aidong Zhou, Kangyu Lin, Sicong Zhang, et al.
EMBO Reports (2017) Vol. 18, Iss. 8, pp. 1318-1330
Open Access | Times Cited: 66
Aidong Zhou, Kangyu Lin, Sicong Zhang, et al.
EMBO Reports (2017) Vol. 18, Iss. 8, pp. 1318-1330
Open Access | Times Cited: 66
A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer
Xiangling Chen, Chengli Yu, Jing Gao, et al.
Theranostics (2018) Vol. 8, Iss. 9, pp. 2348-2360
Open Access | Times Cited: 66
Xiangling Chen, Chengli Yu, Jing Gao, et al.
Theranostics (2018) Vol. 8, Iss. 9, pp. 2348-2360
Open Access | Times Cited: 66
USP1-trapping lesions as a source of DNA replication stress and genomic instability
Kate E. Coleman, Yandong Yin, Sarah Kit Leng Lui, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Kate E. Coleman, Yandong Yin, Sarah Kit Leng Lui, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes
Laura M. Doherty, Caitlin E. Mills, Sarah A. Boswell, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 34
Laura M. Doherty, Caitlin E. Mills, Sarah A. Boswell, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 34
Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes
Olga A. Issaenko, Alexander Y. Amerik
Cell Cycle (2012) Vol. 11, Iss. 9, pp. 1804-1817
Open Access | Times Cited: 72
Olga A. Issaenko, Alexander Y. Amerik
Cell Cycle (2012) Vol. 11, Iss. 9, pp. 1804-1817
Open Access | Times Cited: 72
Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma
Harish Potu, Luke F. Peterson, Malathi Kandarpa, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Harish Potu, Luke F. Peterson, Malathi Kandarpa, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway
Harish Potu, Luke F. Peterson, Anupama Pal, et al.
Oncotarget (2014) Vol. 5, Iss. 14, pp. 5559-5569
Open Access | Times Cited: 60
Harish Potu, Luke F. Peterson, Anupama Pal, et al.
Oncotarget (2014) Vol. 5, Iss. 14, pp. 5559-5569
Open Access | Times Cited: 60
Regulation of Sperm Capacitation by the 26S Proteasome: An Emerging New Paradigm in Spermatology1
Karl Kerns, Patricio Morales, Peter Šutovský
Biology of Reproduction (2016) Vol. 94, Iss. 5
Closed Access | Times Cited: 59
Karl Kerns, Patricio Morales, Peter Šutovský
Biology of Reproduction (2016) Vol. 94, Iss. 5
Closed Access | Times Cited: 59